OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
JUGI56

JPMorgan UK Small Cap Growth & Income PLC

UK Investment TrustsVerified

JPMorgan UK Small Cap Growth & Income PLC has a total equity of £473.02 million and total liabilities of £63.64 million, resulting in a debt-to-equity ratio of 0.13, which is relatively low compared to the industry median for UK investment trusts. The company's liquidity position is characterized by a current ratio of 0.39, indicating that its current liabilities exceed its current assets. This suggests a medium liquidity risk, as the company may struggle to meet short-term obligations without relying on asset sales or external financing. The company's profitability is currently negative, with a return on equity (ROE) of -0.64% and a return on assets (ROA) of -0.56%. These figures are below the industry median for UK investment trusts, which typically report positive ROE and ROA due to the nature of their investment strategies and income generation. The negative net income of £3.02 million and operating income of £2.94 million further underscore the company's underperformance in the current period. The company's revenue is concentrated in the UK market, as it is a UK-domiciled investment trust with a focus on small-cap equities. While the company does not disclose specific geographic revenue breakdowns, the nature of its investment strategy implies a high degree of exposure to the UK equity market. This concentration increases the company's vulnerability to UK-specific economic and regulatory risks. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a decline in revenue, with no clear indication of a turnaround in the next fiscal year. The operating cash flow of £12.8 million provides some buffer, but the negative net income and operating income suggest that the company may need to adjust its investment strategy or raise additional capital to improve its financial position. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt indicates that the company's cash and equivalents (£21.56 million) are insufficient to cover its long-term debt (£60 million). This could necessitate additional financing, which may lead to dilution of existing shareholders. However, the low dilution risk suggests that the company is not currently under significant pressure to issue new shares. Recent events, including the latest financial filing, indicate that the company is experiencing financial challenges. The negative net income and operating income are consistent with a broader trend of underperformance in the UK investment trust sector. The company has not disclosed any major strategic changes or new investment opportunities that could reverse this trend.

30-day price · JUGI+18.00 (+6.0%)
Low$299.00High$336.50Close$320.00As of16 May, 00:00 UTC
Profile
CompanyJPMorgan UK Small Cap Growth & Income PLC
TickerJUGI.L
SectorFinancials
BusinessCollective Investments
Industry groupCollective Investments
IndustryUK Investment Trusts
AI analysis

Business. JPMorgan UK Small Cap Growth & Income PLC is a UK investment trust that invests in small-cap equities and generates income through dividends and capital gains.

Classification. The company is classified under the Financials sector, specifically in the Collective Investments business sector and the UK Investment Trusts industry, with a high confidence level of 0.92.

JPMorgan UK Small Cap Growth & Income PLC has a total equity of £473.02 million and total liabilities of £63.64 million, resulting in a debt-to-equity ratio of 0.13, which is relatively low compared to the industry median for UK investment trusts. The company's liquidity position is characterized by a current ratio of 0.39, indicating that its current liabilities exceed its current assets. This suggests a medium liquidity risk, as the company may struggle to meet short-term obligations without relying on asset sales or external financing. The company's profitability is currently negative, with a return on equity (ROE) of -0.64% and a return on assets (ROA) of -0.56%. These figures are below the industry median for UK investment trusts, which typically report positive ROE and ROA due to the nature of their investment strategies and income generation. The negative net income of £3.02 million and operating income of £2.94 million further underscore the company's underperformance in the current period. The company's revenue is concentrated in the UK market, as it is a UK-domiciled investment trust with a focus on small-cap equities. While the company does not disclose specific geographic revenue breakdowns, the nature of its investment strategy implies a high degree of exposure to the UK equity market. This concentration increases the company's vulnerability to UK-specific economic and regulatory risks. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a decline in revenue, with no clear indication of a turnaround in the next fiscal year. The operating cash flow of £12.8 million provides some buffer, but the negative net income and operating income suggest that the company may need to adjust its investment strategy or raise additional capital to improve its financial position. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt indicates that the company's cash and equivalents (£21.56 million) are insufficient to cover its long-term debt (£60 million). This could necessitate additional financing, which may lead to dilution of existing shareholders. However, the low dilution risk suggests that the company is not currently under significant pressure to issue new shares. Recent events, including the latest financial filing, indicate that the company is experiencing financial challenges. The negative net income and operating income are consistent with a broader trend of underperformance in the UK investment trust sector. The company has not disclosed any major strategic changes or new investment opportunities that could reverse this trend.
Key takeaways
  • JPMorgan UK Small Cap Growth & Income PLC has a low debt-to-equity ratio of 0.13, indicating a conservative capital structure.
  • The company's return on equity and return on assets are negative, suggesting poor profitability compared to industry medians.
  • The company's liquidity position is weak, with a current ratio of 0.39, indicating potential short-term financial stress.
  • The company's revenue is concentrated in the UK market, increasing its exposure to UK-specific economic and regulatory risks.
  • The company's growth trajectory is uncertain, with no clear indication of a turnaround in the next fiscal year.
  • The company faces a medium liquidity risk and a low dilution risk, with key flags indicating potential financing needs.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue$3.7M
Gross profit-$2.1M
Operating income-$2.9M
Net income-$3.0M
R&D
SG&A
D&A
SBC
Operating cash flow$12.8M
CapEx
Free cash flow
Total assets$536.7M
Total liabilities$63.6M
Total equity$473.0M
Cash & equivalents$21.6M
Long-term debt$60.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$473.0M
Net cash-$38.4M
Current ratio0.4
Debt/Equity0.1
ROA-0.6%
ROE-0.6%
Cash conversion-4.2%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: UK Investment Trusts · cohort 1 companies
MetricJUGIActivity
Op margin-79.9%86.0% medp25 53.6% · p75 95.9%bottom quartile
Net margin-81.9%84.2% medp25 47.0% · p75 95.4%bottom quartile
Gross margin-57.5%90.3% medp25 73.4% · p75 97.4%bottom quartile
CapEx / revenue-0.1% medp25 -0.1% · p75 -0.1%
Debt / equity13.0%3.8% medp25 0.0% · p75 9.5%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 22:41 UTC#d5f7197c
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 07:05 UTCJob: 0bcf598d